Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03158571 |
Date of registration:
|
16/05/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Chilean Gastric Cancer Task Force (FORCE 1)
FORCE-1 |
Scientific title:
|
Chilean Gastric Cancer Task Force (FORCE 1): A Study Protocol to Obtain a Clinical and Molecular Classification of a Cohort of Gastric Cancer Patients. |
Date of first enrolment:
|
January 1, 2017 |
Target sample size:
|
116 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03158571 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Chile
| | | | | | | |
Contacts
|
Name:
|
Marcelo Garrido, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Pontificia Universidad Catolica de Chile |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosed with gastric cancer (histological or cytological) Attending health centers
of the Red UC Christus network for at least 3 months with clinical follow-up.
Capable to read and speak spanish Willing and able to provide written informed consent to
eh study that should be dated and signed informed consent
Exclusion Criteria:
- With small biopsy samples insufficient for analysis. Whose medical records cannot be
collected or are unavaible Without signed informed consent.
Age minimum:
18 Years
Age maximum:
99 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Biomarkers
|
Primary Outcome(s)
|
Overall survival
[Time Frame: two years]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|